These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6849446)

  • 1. Desipramine and methylphenidate combination treatment for depression: case report.
    Drimmer EJ; Gitlin MJ; Gwirtsman HE
    Am J Psychiatry; 1983 Feb; 140(2):241-2. PubMed ID: 6849446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine.
    Fernandez F; Levy JK; Samley HR; Pirozzolo FJ; Lachar D; Crowley J; Adams S; Ross B; Ruiz P
    Int J Psychiatry Med; 1995; 25(1):53-67. PubMed ID: 7649718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.
    Rapport MD; Carlson GA; Kelly KL; Pataki C
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):333-42. PubMed ID: 8444762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential clinical use for methylphenidate with tricyclic antidepressants.
    Wharton RN; Perel JM; Dayton PG; Malitz S
    Am J Psychiatry; 1971 Jun; 127(12):1619-25. PubMed ID: 4998422
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute response to methylphenidate as a predictor of outcome of treatment with TCAs in the elderly.
    Spar JA; La Rue A
    J Clin Psychiatry; 1985 Nov; 46(11):466-9. PubMed ID: 4055706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of methylphenidate and desipramine alone and in combination in children.
    Pataki CS; Carlson GA; Kelly KL; Rapport MD; Biancaniello TM
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1065-72. PubMed ID: 8407753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disputing preliminary findings on methylphenidate-desipramine responses.
    Mattes JA
    Am J Psychiatry; 1983 Sep; 140(9):1273. PubMed ID: 6614262
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequence of drug administration in lithium augmentation: a case study.
    Price LH; Delgado PL; Charney DS; Heninger GR
    J Clin Psychiatry; 1988 Apr; 49(4):161-2. PubMed ID: 3356674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and thyroid hormone levels.
    Joffe RT; Singer W
    Acta Med Austriaca; 1992; 19 Suppl 1():96-7. PubMed ID: 1519466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined tricyclic and MAOI treatment of depressed patients.
    Raskin DE
    Am J Psychiatry; 1983 Oct; 140(10):1384. PubMed ID: 6624980
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the effects of desipramine treatment alone and in combination with L-triiodothyronine on 6-sulphatoxymelatonin excretion in depressed patients.
    Bearn J; Franey C; Arendt J; Checkley SA
    Br J Psychiatry; 1989 Sep; 155():341-7. PubMed ID: 2611544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine.
    Schwarcz G; Halaris A; Baxter L; Escobar J; Thompson M; Young M
    Am J Psychiatry; 1984 Dec; 141(12):1614-6. PubMed ID: 6439059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
    Eisen A
    Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylphenidate in a patient with depression and respiratory insufficiency.
    Ayache DC; Junior RF
    Int J Psychiatry Med; 2001; 31(4):443-9. PubMed ID: 11949742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior antidepressant treatment does not have an impact on response to desipramine treatment in major depression.
    Young LT; Cooke RG; Levitt AJ; Joffe RT
    Biol Psychiatry; 1995 Sep; 38(6):410-2. PubMed ID: 8547462
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports.
    Michals M; Stanley DA; Crismon ML; Barrow NE
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):466-7. PubMed ID: 2136405
    [No Abstract]   [Full Text] [Related]  

  • 19. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.